drugset / Trial / NCT05141838

Vitamin D Status and Bone Metabolism Status in Children With Congenital Epidermolysis Bullosa

NCT05141838

Non-randomizedParallel-groupOpen-labelTreatment

Summary

This retrospective prospective study is aimed at studying the level of vitamin D supply and identifying markers of bone tissue remodeling in order to develop approaches to the prevention of osteopenia and osteoporosis in children with congenital epidermolysis bullosa.

Timeline

Start
2020-11-21
Primary completion
2023-01-01
Completion
2023-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin D Other / unclassified